Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.

Irmak KaracaElaine M TranSungWho ParkAlbert BromeoHassan KhojastehAnh Ngọc Tram TranNegin YavariAmir AkhavanrezayatCigdem YasarGunay Uludag KirimliNgoc Tuong Trong ThanMuhammad HassanChristopher OrHashem GhorabaDiana V DoQuan Dong Nguyen

Published in: Journal of ophthalmic inflammation and infection (2024)

CP therapy can be considered a potentially effective and relatively safe therapeutic option for patients with severe ocular inflammatory diseases who failed other IMTs including biologics (TNFa and CD20 inhibitors).

Keyphrases

high dose
oxidative stress
early onset
low dose
stem cells
drug induced
cell therapy
optical coherence tomography
chemotherapy induced